MedicinemedRxiv
Heuristic editor, no API keyVerdict: NotableAutomated, Component-Level Assessment of a National Inpatient Diabetes Guideline: Adherence and Its Association with Hospitalization Complications Across Six Hospitals
Objective: To measure adherence to a national inpatient hyperglycemia guideline at the level of its individual recommendations across a hospital network, to determine whether it changed after the guideline was issued…
Key numbers
- 44% lower odds of 30
- 95% CI
- 82% lower odds of hyperglycemia
VerdictWorth a reader's time today.
Abstract
Objective: To measure adherence to a national inpatient hyperglycemia guideline at the level of its individual recommendations across a hospital network, to determine whether it changed after the guideline was issued, and to identify which recommendations track subsequent outcomes. Materials and Methods: Retrospective multicenter study of 48,354 admissions among 29,577 adults with diabetes or inpatient hyperglycemia at six Israeli general hospitals, August 2022 to December 2025. Each of 14 recommendations was formalized as a quality-assessment temporal pattern over knowledge-based temporal abstractions of the record, scored wherever it applied. Pre-post adherence was compared by Welch t-test with false discovery rate correction. Associations with 10 complications were estimated by bias-reduced logistic regression over 24-, 48-, and 72-hour windows, and by inverse probability of treatment weighting contrasting above- with at-or-below-median adherence. Results: Adherence ranged from near-universal admission and medication-management actions to substantial gaps in insulin management (means, 0.15-0.28). Overall adherence rose modestly after issue (0.682 to 0.703, P < .001), with marked inter-hospital heterogeneity. After weighting, above-median adherence carried 44% lower odds of 30-day mortality (odds ratio [OR], 0.557; 95% CI, 0.514-0.603), 82% lower odds of hyperglycemia (OR, 0.175) and 52% lower odds of severe hyperglycemia (OR, 0.485), against 20% higher odds of hypoglycemia (OR, 1.204). Discussion: The least-implemented recommendations were largely those whose adherence tracked outcomes: repeated insulin decisions spread across a stay, rather than discrete actions on admission. Conclusion: Guideline adherence can be assessed automatically and per-recommendation at national scale, identifying where fuller implementation would most plausibly matter. Keywords: inpatient diabetes; clinical guideline adherence; quality assessment; temporal abstraction; electronic health records; propensity score; causal inference
The editor's rubric
| Dimension | Level | Weight | What that level means |
|---|---|---|---|
| Leverage | ███░░ 3 | 10% | A method or resource many groups across the field will adopt within a year. |
| Magnitude | ███░░ 3 | 20% | Large gain: roughly 2x, or a clear new state of the art on a hard, unsaturated problem. |
| Evidence | ████░ 4 | 32% | Strong: large scale, preregistered, independently replicated, or a well-powered randomized trial. |
| Novelty | ███░░ 3 | 8% | A genuinely new approach to an open problem. |
| Trajectory | ███░░ 3 | 5% | A clear path to scale. |
| Stakes | ███░░ 3 | 25% | Meaningful benefit to many people within a few years. |
Editor’s rationale
Heuristic triage from title and abstract text only, not a reading of the paper. Cues found: breadth (general-purpose); gains (efficacy); novelty (alternative to status quo, discovery); design (multicenter); verification (confidence interval, p-value); scale (scalable); stakes (mortality, major disease, prevention or cure). Red flags: weak evidence (single site).
How the score was computed
- Merit
- 6.6 / 10
- Adjusted merit
- 5.3 / 10
- Attention
- 0%
- Freshness
- 84%
- Citations0 (reference 20, via openalex, Sep 29, 2026, 23:37 UTC)